Cargando…

Hepatocellular carcinoma with biliary and neuroendocrine differentiation: A case report

BACKGROUND: Liver tumors with dual differentiations [combined hepatocellular carcinoma (HCC) and cholangiocarcinoma] are common. However, liver tumors that exhibit hepatocellular, biliary, and neuroendocrine differentiation are exceedingly rare, with only three previous case reports in the literatur...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimopoulos, Yiannis Petros, Winslow, Emily R, He, Aiwu Ruth, Ozdemirli, Metin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085510/
https://www.ncbi.nlm.nih.gov/pubmed/33959479
http://dx.doi.org/10.5306/wjco.v12.i4.262
_version_ 1783686356223918080
author Dimopoulos, Yiannis Petros
Winslow, Emily R
He, Aiwu Ruth
Ozdemirli, Metin
author_facet Dimopoulos, Yiannis Petros
Winslow, Emily R
He, Aiwu Ruth
Ozdemirli, Metin
author_sort Dimopoulos, Yiannis Petros
collection PubMed
description BACKGROUND: Liver tumors with dual differentiations [combined hepatocellular carcinoma (HCC) and cholangiocarcinoma] are common. However, liver tumors that exhibit hepatocellular, biliary, and neuroendocrine differentiation are exceedingly rare, with only three previous case reports in the literature. CASE SUMMARY: A 65-year-old female with a previous history of hepatitis C and a distant history of low grade, well-differentiated rectal neuroendocrine tumor was found to have two liver lesions in segment 4 and segment 7 on imaging. Serum alpha-fetoprotein and chromogranin A were elevated. Biopsy of the larger lesion in segment 4 revealed a high-grade tumor, with morphologic and immunohistochemical features of a neuroendocrine tumor. Given the previous history of rectal neuroendocrine tumor, imaging investigation, serologic markers, and biopsy findings, metastatic neuroendocrine tumor was considered. Subsequent regional resection of these hepatic lesions revealed the segment 4 lesion to be a HCC with additional biliary and neuroendocrine differentiation and the segment 7 lesion to be a cholangiocarcinoma with neuroendocrine differentiation. Follow-up of the patient revealed disease recurrence in the dome of the liver and metastasis in retro-pancreatic lymph nodes. The patient eventually expired due to complications of chemotherapy. CONCLUSION: HCC cases with additional biliary and neuroendocrine differentiation are exceedingly rare, posing a diagnostic challenge for clinicians and pathologists.
format Online
Article
Text
id pubmed-8085510
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-80855102021-05-05 Hepatocellular carcinoma with biliary and neuroendocrine differentiation: A case report Dimopoulos, Yiannis Petros Winslow, Emily R He, Aiwu Ruth Ozdemirli, Metin World J Clin Oncol Case Report BACKGROUND: Liver tumors with dual differentiations [combined hepatocellular carcinoma (HCC) and cholangiocarcinoma] are common. However, liver tumors that exhibit hepatocellular, biliary, and neuroendocrine differentiation are exceedingly rare, with only three previous case reports in the literature. CASE SUMMARY: A 65-year-old female with a previous history of hepatitis C and a distant history of low grade, well-differentiated rectal neuroendocrine tumor was found to have two liver lesions in segment 4 and segment 7 on imaging. Serum alpha-fetoprotein and chromogranin A were elevated. Biopsy of the larger lesion in segment 4 revealed a high-grade tumor, with morphologic and immunohistochemical features of a neuroendocrine tumor. Given the previous history of rectal neuroendocrine tumor, imaging investigation, serologic markers, and biopsy findings, metastatic neuroendocrine tumor was considered. Subsequent regional resection of these hepatic lesions revealed the segment 4 lesion to be a HCC with additional biliary and neuroendocrine differentiation and the segment 7 lesion to be a cholangiocarcinoma with neuroendocrine differentiation. Follow-up of the patient revealed disease recurrence in the dome of the liver and metastasis in retro-pancreatic lymph nodes. The patient eventually expired due to complications of chemotherapy. CONCLUSION: HCC cases with additional biliary and neuroendocrine differentiation are exceedingly rare, posing a diagnostic challenge for clinicians and pathologists. Baishideng Publishing Group Inc 2021-04-24 2021-04-24 /pmc/articles/PMC8085510/ /pubmed/33959479 http://dx.doi.org/10.5306/wjco.v12.i4.262 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Case Report
Dimopoulos, Yiannis Petros
Winslow, Emily R
He, Aiwu Ruth
Ozdemirli, Metin
Hepatocellular carcinoma with biliary and neuroendocrine differentiation: A case report
title Hepatocellular carcinoma with biliary and neuroendocrine differentiation: A case report
title_full Hepatocellular carcinoma with biliary and neuroendocrine differentiation: A case report
title_fullStr Hepatocellular carcinoma with biliary and neuroendocrine differentiation: A case report
title_full_unstemmed Hepatocellular carcinoma with biliary and neuroendocrine differentiation: A case report
title_short Hepatocellular carcinoma with biliary and neuroendocrine differentiation: A case report
title_sort hepatocellular carcinoma with biliary and neuroendocrine differentiation: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085510/
https://www.ncbi.nlm.nih.gov/pubmed/33959479
http://dx.doi.org/10.5306/wjco.v12.i4.262
work_keys_str_mv AT dimopoulosyiannispetros hepatocellularcarcinomawithbiliaryandneuroendocrinedifferentiationacasereport
AT winslowemilyr hepatocellularcarcinomawithbiliaryandneuroendocrinedifferentiationacasereport
AT heaiwuruth hepatocellularcarcinomawithbiliaryandneuroendocrinedifferentiationacasereport
AT ozdemirlimetin hepatocellularcarcinomawithbiliaryandneuroendocrinedifferentiationacasereport